Free Trial
ASX:BOT

Botanix Pharmaceuticals (BOT) Stock Price, News & Analysis

Botanix Pharmaceuticals logo

About Botanix Pharmaceuticals Stock (ASX:BOT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.63 million shs
Average Volume
N/A
Market Capitalization
A$912.82 million
P/E Ratio
N/A
Dividend Yield
2.96%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BOT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Botanix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

BOT Stock News Headlines

BOT - Botanix Pharmaceuticals Ltd Chart - Morningstar
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
Botanix Pharmaceuticals Limited (BOT.AX)
See More Headlines

BOT Stock Analysis - Frequently Asked Questions

Botanix Pharmaceuticals Limited (ASX:BOT) issued its quarterly earnings data on Thursday, February, 28th. The company reported ($0.01) earnings per share (EPS) for the quarter. Botanix Pharmaceuticals had a negative net margin of 670.20% and a negative trailing twelve-month return on equity of 18.00%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Botanix Pharmaceuticals investors own include Alphabet (GOOG), Meta Platforms (META), Arafura Rare Earths (ARU), Canopy Growth (CGC), Manning & Napier (MN), (STB.TO) (STB) and (YCB) (YCB).

Company Calendar

Last Earnings
2/28/2019
Today
7/05/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:BOT
CIK
N/A
Fax
N/A
Employees
11
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$13.87 million
Net Margins
-670.20%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$2.07 million
Price / Cash Flow
1.50
Book Value
A$0.07 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,810,000,000
Free Float
N/A
Market Cap
A$912.82 million
Optionable
Not Optionable
Beta
1.71
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (ASX:BOT) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners